Citi raised the firm’s price target on iRhythm (IRTC) to $157 from $155 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- Structural Subordination Risk Looms Over iRhythm Holding Company’s Ability to Service 2029 Notes
- iRhythm Technologies Signals Profitable Growth Amid Overhangs
- iRhythm price target raised to $174 from $170 at Truist
- iRhythm price target raised to $175 from $166 at Baird
- iRhythm price target lowered to $175 from $215 at JPMorgan